Therapeutic Neovascularization - Quo vadis?
| Corporate Author: | |
|---|---|
| Other Authors: | , |
| Format: | eBook |
| Language: | English |
| Published: |
Dordrecht :
Springer Netherlands : Imprint: Springer,
2007.
|
| Edition: | 1st ed. 2007. |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/1-4020-5955-8 |
Table of Contents:
- Clinical Vascular Growth Factor Therapy for Neovascularization in Patients with Coronary Artery Disease
- The Strengths and Weaknesses of VEGF Adenovirus-Driven Angiogenesis
- Angiogenesis and Arteriogenesis in Diabetes Mellitus: Signal Transduction Defects as the Molecular Basis of Vascular Cell Dysfunction
- Endothelial Activation and Neointimal Hyperplasia: A Double-Edged Sword
- Pampering and Priming the Heart
- Coronary Venous Retroinfusion: A Novel Venue of Regional Induction of Neovascularization
- Integrative Pro-angiogenic Activation: HIF-?
- The Maturation of Vessels - A Limitation to Forced Neovascularization?
- Vascular and Neuronal Development: Intersecting Parallelisms and rossroads
- Cathelicidin Antimicrobial Peptides Modulate Angiogenesis
- The Biology of Embryonic and Adult Endothelial Progenitor Cells
- Signaling Behind Progenitor Cell Mobilization: Focus on Enos and Caveolin
- The Role of Monocytes/Macrophages and Vascular Resident Precursor Cells in Collateral Growth.